Literature DB >> 20495828

LPA receptor expression in the central nervous system in health and following injury.

Yona Goldshmit1, Kathryn Munro, Soo Yuen Leong, Alice Pébay, Ann M Turnley.   

Abstract

Lysophosphatidic acid (LPA) is released from platelets following injury and also plays a role in neural development but little is known about its effects in the adult central nervous system (CNS). We have examined the expression of LPA receptors 1-3 (LPA(1-3)) in intact mouse spinal cord and cortical tissues and following injury. In intact and injured tissues, LPA(1) was expressed by ependymal cells in the central canal of the spinal cord and was upregulated in reactive astrocytes following spinal cord injury. LPA(2) showed low expression in intact CNS tissue, on grey matter astrocytes in spinal cord and in ependymal cells lining the lateral ventricle. Following injury, its expression was upregulated on astrocytes in both cortex and spinal cord. LPA(3) showed low expression in intact CNS tissue, viz. on cortical neurons and motor neurons in the spinal cord, and was upregulated on neurons in both regions after injury. Therefore, LPA(1-3) are differentially expressed in the CNS and their expression is upregulated in response to injury. LPA release following CNS injury may have different consequences for each cell type because of this differential expression in the adult nervous system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495828     DOI: 10.1007/s00441-010-0977-5

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  19 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

2.  Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes.

Authors:  Yona Goldshmit; Rosalia Matteo; Tamar Sztal; Felix Ellett; Frisca Frisca; Kelli Moreno; Duncan Crombie; Graham J Lieschke; Peter D Currie; Roger A Sabbadini; Alice Pébay
Journal:  Am J Pathol       Date:  2012-07-20       Impact factor: 4.307

3.  Modulation of LPA receptor expression in the human brain following neurotrauma.

Authors:  Tony Frugier; Duncan Crombie; Alison Conquest; Frisca Tjhong; Caroline Taylor; Tejal Kulkarni; Catriona McLean; Alice Pébay
Journal:  Cell Mol Neurobiol       Date:  2011-01-15       Impact factor: 5.046

Review 4.  Lysophosphatidic Acid signaling in the nervous system.

Authors:  Yun C Yung; Nicole C Stoddard; Hope Mirendil; Jerold Chun
Journal:  Neuron       Date:  2015-02-18       Impact factor: 17.173

5.  Matrix-Assisted Laser Desorption Ionization Mapping of Lysophosphatidic Acid Changes after Traumatic Brain Injury and the Relationship to Cellular Pathology.

Authors:  Whitney S McDonald; Elizabeth E Jones; Jonathan M Wojciak; Richard R Drake; Roger A Sabbadini; Neil G Harris
Journal:  Am J Pathol       Date:  2018-07-16       Impact factor: 4.307

6.  Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid.

Authors:  Ngoc H On; Sanjot Savant; Myron Toews; Donald W Miller
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-18       Impact factor: 6.200

Review 7.  Lysophospholipids and their receptors in the central nervous system.

Authors:  Ji Woong Choi; Jerold Chun
Journal:  Biochim Biophys Acta       Date:  2012-07-31

Review 8.  Lysophosphatidic Acid Signalling in Nervous System Development and Function.

Authors:  Eric Birgbauer
Journal:  Neuromolecular Med       Date:  2020-11-05       Impact factor: 3.843

9.  Interleukin-1β plays key roles in LPA-induced amplification of LPA production in neuropathic pain model.

Authors:  Ryo Yano; Lin Ma; Jun Nagai; Hiroshi Ueda
Journal:  Cell Mol Neurobiol       Date:  2013-08-15       Impact factor: 5.046

10.  An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model.

Authors:  Lin Ma; Jun Nagai; Jerold Chun; Hiroshi Ueda
Journal:  Mol Pain       Date:  2013-06-17       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.